JACARDI’s Post

#JACARDI is happy to embrace the Council`s Conclusion on the EU Cardiovascular Health Plan, #CVHPlan. #EU is taking action to adopt Council`s Conclusion to actively prevent and treat #CVDs. In JACARDI we are right in the core of these activities, as we are searching for answers and coming up with solutions to fight the ever increasing burden of CVDs and #NCDs. #EU4Health #preventingCVDs

🎉Huge milestone! The EU has adopted Council conclusions on the improvement of cardiovascular health 🎉 This includes strengthening primary and secondary prevention, early detection and screening, and optimising management and rehabilitative care of CVD. The Council conclusions also call on the European Commission to ensure adequate funding and to map cardiovascular health actions in an integrated way, through primary, secondary and tertiary care. Proposed steps include promoting evidence-based prevention measures, advancing innovative treatments, and leveraging digital health tools for better data integration and research. These actions aim to reduce risk factors common to both cardiovascular diseases and cancer, such as poor nutrition, tobacco use, and physical inactivity. Read the Press Release from European Alliance for Cardiovascular Health (EACH) 👇

Decision today by Council of the European Union: Cardiovascular health: Council calls for more robust efforts to help prevent cardiovascular diseases "The Council is calling for more robust efforts to help prevent cardiovascular diseases, which are the leading cause of death in the European Union. In conclusions approved today, the Council puts forward a series of measures aimed at improving cardiovascular health in the EU, focusing specifically on prevention, early detection, treatment and rehabilitation. Cardiovascular diseases have a devastating impact on individuals and their families, yet in most cases they can be prevented by addressing underlying risk factors through healthier lifestyle choices. Screening and better access to treatment are essential elements to reduce the impact of CVDs. Today’s conclusions reflect our commitment to improving cardiovascular health throughout the EU. Péter Takács, Hungarian Secretary of State for Health In its conclusions, the Council pushes for particular attention to be given to preventive measures such as improving health literacy, raising awareness about cardiovascular health, and discouraging unhealthy lifestyle choices like tobacco use, excessive alcohol consumption or an unhealthy diet. The Council also calls on member states to ensure equal access to cardiovascular healthcare, incorporate screening into regular health checks, and strengthen training for healthcare workers. Finally, the Council invites the Commission to take comprehensive action to help reduce the prevalence of cardiovascular diseases in the EU, emphasising not only health promotion and prevention but also screening, early detection, treatment, rehabilitation, and advancing research and innovation." @EACH European Society of Cardiology @heartfailure policy network

It is promising to see current alignment between major European cardiovascular disease (CVD) stakeholders – politicians, medical experts, patients and industry – as outlined at the first High-Level Conference on Cardiovascular Health last week in Budapest. This ushers in a promising and unprecedented opportunity to recognize the importance of innovation to tackle CVD while boosting competitiveness of the EU life sciences industry. It is critical that Europe takes urgent action and a systematic approach to address CVD. This includes adoption of a European Cardiovascular Health Plan, the implementation of national Cardiovascular Health Plans across all EU Member States, and access to innovative tools such as targeted health checks for major modifiable CVD risk factors, such as high LDL cholesterol and diabetes. https://lnkd.in/dbBiiF_T  

The Hungarian high level meeting on cardiovascular health #CVH in Europe was our 3rd EU Presidency meeting, where awareness of inherited lipid conditions (familial hyperlipidaemias) as common genetic CVD risk factors was raised. More importantly - it was a fantastic platform to showcase examples of successful implementation of early screening and detection programmes, and the urgency to act in the mission to prevent the preventable. FH in its both forms (HeFH and HoFH), elevated Lp(a) and even FCS contribute to CVD, where FH affects individuals very early in life, causing premature heart attack(s), even death. All of them however can be easily detected and an early adoption of preventative measures can effectively stop the cardiovascular disease development and progression. Beyond the human cost of estimated 1.7 million deaths per year, CVD costs the EU 282 billion EUR, that's 100 billion EUR more that the overall budget of the EU. And yet, currently there is no strategy to tackle this public problem. Europe needs a Cardiovascular Health Action Plan, Europeans deserve #CVHealthForAll! Read more about the #HU24EU conference, the highlights and the key takeaways, including the FH Europe Foundation's delegation engaging with the international politicians and policy influencers, promoting the #PragueDeclaration and #PerfectoFH as blueprints for innovation, personalised prevention, precision medicine and innovation in tackling CVD and promoting CVH. European Alliance for Cardiovascular Health (EACH) JACARDI PERFECTO - FH #UseHeart and #FindFH #FindHoFH #FindLpa #FindFCS #Cholesterol #genetics #PrecisionMedicine #Innovation #FHchildscreening #LpaMeasurement #RareCVDs #InheritedLipids #VoteHealth #PatientEngagement #PatientAmbassadors #FHEurope Magdalena Daccord Nicola Bedlington Marius Geanta, MD Ákos Gábor Gesztes PharmD

11 experts on why gains in cardiovascular disease are stalling and what we can do about it The American Heart Association set an ambitious objective to reduce cardiovascular disease and stroke-related deaths by 20% by the conclusion of 2020, emphasizing the critical need for action in this health domain. Although there was a 15% decline in deaths compared to 2010, the outcomes did not meet expectations, as numerous fatalities associated with high blood pressure, heart failure, and atrial fibrillation persisted. Additionally, achieving "ideal cardiovascular health" remains challenging, with less than 1 in 10 Americans meeting the criteria. Contributing factors to this stagnation encompass overlapping chronic conditions, substantial health inequities, and lifestyle elements such as poor dietary habits and physical inactivity. Inadequate adherence to treatment regimens, an aging populace, and data gaps exacerbate the issue, while mental health often goes unaddressed in cardiovascular disease management. It is imperative for healthcare professionals, policymakers, and the general populace to confront these concerns through enhanced healthcare accessibility, public awareness initiatives, technological advancements, and community involvement. Each individual has a role to fulfill in reversing this trend and enhancing cardiovascular health outcomes.

We need to put #longcovid #mecfs and other covid sequelae on the European agenda. Long Covid Europe presented at the European Council health committee earlier this year, but the topic has not really been addressed well to any concrete steps.

As far as the new study presented this week at the AHA conference (see: https://lnkd.in/g7YHedz4), the study used just two measurements of 24-hour dietary recall to assign who was fasting and not fasting, so it is a very poor measure of long-term behavior. They examined the time-restricted eating (TRE) form of #IntermittentFasting by defining it as the time between their first meal of the day and the last time they ate, and people who ate over just 8 hours or less were assigned as TRE. Many of the people who the researchers assigned to be users of TRE were likely unaware that they might be fasting and may not even have known what TRE is or why they might engage in it. It appears further that the people who were evaluated in the study comprised a mix of individuals who probably included some people actually engaging in TRE to improve their health and who were healthy enough to do an intense fasting regimen. However, the study was just a general US population that the US Centers for Disease Control and Prevention (CDC) enrolled in the NHANES study from 2003-2018, so it also undoubtedly included people who were too sick to safely engage in fasting. Some of those sicker individuals who had a diagnosis such as cardiovascular disease or cancer may have decided to do an intense fasting regimen to reverse their disease and, thereby, caused more harm than good to themselves. I have seen people like this in the observational datasets that my colleagues and I at Intermountain Health have created through an observational evaluation of fasting behavior since 2002. We survey people about fasting behavior and keep those data in a registry called the INSPIRE study. In one evaluation, a small subset of people had recently started engaging in fasting and also had multiple risk factors and comorbidities (e.g., atrial fibrillation, heart failure, coronary heart disease, heart attack, diabetes, and/or stroke, in addition to obesity). Their risk of death was not lower than people who did not engage in fasting, although the risk of death was lower for people who had been fasting routinely for many years using a periodic fasting behavior of low-dose approximately once-per-month 24-hour fasting (in our study, routine periodic fasting was associated with a significantly LOWER risk of death than not fasting—that is, #fasting increased #longevity: https://lnkd.in/gq7CEAVi). Such data suggest caution for people with multiple major chronic diseases and major risk factors. Prudence indicates that a more personalized regimen of fasting is better for people with major health concerns and it is wise to have such a regimen guided and monitored by a physician. Ultimately, the new AHA study likely included some people who similarly received a chronic disease diagnosis and decided to do an intense regimen of fasting, which led to adverse consequences due to fasting too much for their present health condition.

Published in the European Journal of Preventive Cardiology, cardiology experts including our NUHCS team of medical professionals, provided critical insights on the rising Cardiovascular Disease (CVD) epidemic in the research paper "Global burden of cardiovascular diseases: projections from 2025 to 2050". The research revealed key findings such as: • A 30% decrease in age-standardised cardiovascular mortality, driven by improved medical care. • A 73% rise in crude CVD mortality, primarily due to an aging population. • High blood pressure, dietary risks, and elevated LDL remain significant risk factors of CVD. The research emphasises the urgent need for tailored interventions globally, addressing region-specific challenges, while offering hope with emerging cardiometabolic therapies that promise innovative solutions for the future. Read more: https://lnkd.in/gtU83yVx #NUHCS #CardiovascularDisease #CVDPrevention #HeartHealth